期刊文献+

HLA基因与再生障碍性贫血相关性研究 被引量:5

Correlation of HLA-Alleles with Aplastic Anemia
下载PDF
导出
摘要 本研究探讨HLA基因与再生障碍性贫血(aplastic anemia,AA)发病之间的相关性。采用序列特异性引物聚合酶链反应(PCR-SSP)分型技术,对82例再生障碍性贫血患者和400名正常对照者进行HLA基因分型,分析HLA基因分布频率在两组中的差异。结果表明:AA组与正常对照组相比,HLA-A*2301(1.84%)、B*5501(4.36%)、DRB1*0901(23.49%)基因频率明显增高,相对危险性(relativerisk,RR分别为5.0253、3.3645和2.1269,χ2为4.6634、6.3120、9.1511)(p<0.01)。AA组DRB1*1301基因频率(1.23%)显著低于正常对照组,其RR为0.2257,χ2=6.66294(p<0.01)。结论:HLA-A*2301、B*5501、DRB1*0901基因可分别作为AA发病的危险标志,而DRB1*1301可作为AA的保护标志。 To investigate the correlation between the HLA genes and pathogenesis of aplastic anemia ( AA), polymerase chain reaction with specific sequence primers (PCR-SSP) method was used to HLA typing in 82 patients with AA and 400 normal healthy individuals as control. The results showed that A * 2301 ( 1.84% ) , B * 5501 (4.36%) and DRB1 * 0901 (23.48%) gene frequency in AA patients were significantly higher than those in controls (relative risk: RR=5.0253,3. 3645,2. 1269, X^ =4. 6634,6. 3120,9. 1511 respectively) (p 〈0.01 ). In contrast, DRB1 * 1301 ( 1.23% ) gene frequency was significantly lower in AA than that in controls, RR =0. 2257, X^2=6. 6629 (p 〈0.01 ). It is concluded that A .2301 ,B .5501 and DRB1 .0901 genes may be considered as the risk markers while DRB1 * 1301 gene as a protective marker of AA.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第6期1208-1211,共4页 Journal of Experimental Hematology
基金 天津市科技发展计划项目 编号06YFSYSF01900
关键词 再生障碍性贫血 HLA基因 基因频率 相对危险性 aplastic anemia HLA gene gene frequency relative risk
  • 相关文献

参考文献8

  • 1Rigas B. HLA and Diseaes Association: the case and gastric cancer.Gastroenterology, 1996 ; 111 : 523 - 526
  • 2Chapuis B, Von-Fliedner VE, Jeannet M, et al. Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their Parents. Br J Haematol, 1986; 63:51 -57
  • 3Lee J. The HLA system - a new Approach . New York, Springer. 1990:120-178
  • 4Albert E, Thomas ED, Nisperos B, et al. HLA antigens and haplotypes in 200 Patients with aplastic anemia. Transptantation, 1976 ; 22:528 - 531
  • 5殷石,马文成,朱卫国,孔炳科,杨绍忠.再生障碍性贫血与人类白细胞抗原相关性研究[J].武警医学,1997,8(5):255-256. 被引量:2
  • 6杨华,孙明艳,张伟杰,曹峰林,马军.再生障碍性贫血与HLA相关性研究[J].哈尔滨医药,1997,17(4):11-12. 被引量:2
  • 7杨碧云,汤爱萍,石庆之,李慧慧,曹瑞生,华建媛.再生障碍性贫血患者HLA-DR B_1*1501检测[J].中华血液学杂志,2002,23(5):276-276. 被引量:3
  • 8Terasaki P, David G. HLA 1997. California USA: UCLA Tissue Typing Lab. 1997:213 - 312

二级参考文献2

  • 1张之南.血液学诊断及疗效标准(第1版)[M].天津:天津科学技术出版社,1991.31-32.
  • 2赵桐茂.HLA分型原理和应用[M]上海科学技术出版社,1984.

共引文献4

同被引文献61

  • 1吴秀丽,李扬秋,王震,陈少华,杨力建,张洹,朱康儿,韩忠朝.免疫相关转录因子GATA-3基因在再障和正常骨髓基质细胞中的表达[J].中国病理生理杂志,2006,22(2):219-222. 被引量:4
  • 2王晓春,张阳德,王铁兵,陈海霞.CYP2E1和GSTM1多态性与再生障碍性贫血遗传易感性研究[J].检验医学,2007,22(3):287-290. 被引量:4
  • 3Hafez MM, el-Wehedy GF, el-Kholy NM, et al. The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma[ J]. Int J Cancer, 1985, 36(1) : 19 -22.
  • 4Falk J, Osoba D. HL-A antigens and survival in Hodgkin's disease [J]. Lancet, 1971, 2:1118-1120.
  • 5Niens M, Jarrett RF, Hepkema B, et al. HLA-A * 02 is associated with a reduced risk and HLA-A * 01 with an increased risk of develo- ping EBV + Hodgkin lymphoma[ J]. Blood, 2007, 110(9) : 3310 - 3315.
  • 6Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell re- sponse in EBV-related Hodgkin lymphoma [ J ]. Proc Natl Acad Sci USA, 2010, 107(14) : 6400 -6405.
  • 7Huang X, van den Berg A, Gao Z, et al. Expression of HLA class 1 and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients[J]. PLoS One, 2010, 5(5) : e10865,.
  • 8Diepstra A, van Imhoff GW, Karim-Kos HE, et al. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognosticfactor in classical Hodgkin's lymphoma[ J ]. J Clin Oncol, 2007, 25 (21) : 3101 -3108.
  • 9Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class Ⅲ in Epstein- Barr-virus-negative Hodgkin' s lymphoma [ J ]. Lancet, 2005, 365 ( 9478 ) : 2216 - 2224.
  • 10Straathof KC, Leen AM, Buza EL, et al. Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV- Positive Nasopharyngeal Carcinoma and Lymphoma [ J ]. J Immunol, 2005, 175 : 4137 -4147.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部